Phase II Trial Of Neoadjuvant Axitinib In Patients With Locally Advanced Non-Metastatic Clear Cell Renal Cell Carcinoma

BACKGROUND: Previous studies have shown modest impact of tyrosine kinase inhibitors on primary renal tumors. These studies were mostly retrospective and heterogeneous in their eligibility criteria with regards to histology, disease stage, duration of therapy, and time off therapy prior to surgery. O...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur Urol
Main Authors: Karam, Jose A., Devine, Catherine E., Urbauer, Diana L., Lozano, Marisa, Maity, Tapati, Ahrar, Kamran, Tamboli, Pheroze, Tannir, Nizar M., Wood, Christopher G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4396847/
https://ncbi.nlm.nih.gov/pubmed/24560330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.01.035
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados